Annual CAPEX
$1.25 M
-$606.00 K-32.62%
December 31, 2023
Summary
- As of February 10, 2025, NGM annual capital expenditures is $1.25 million, with the most recent change of -$606.00 thousand (-32.62%) on December 31, 2023.
- During the last 3 years, NGM annual CAPEX has fallen by -$627.00 thousand (-33.37%).
Performance
NGM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CAPEX
$188.00 K
-$102.00 K-35.17%
December 31, 2023
Summary
- As of February 10, 2025, NGM quarterly capital expenditures is $188.00 thousand, with the most recent change of -$102.00 thousand (-35.17%) on December 31, 2023.
- Over the past year, NGM quarterly CAPEX has dropped by -$482.00 thousand (-71.94%).
Performance
NGM Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
$1.25 M
-$253.00 K-16.81%
December 31, 2023
Summary
- As of February 10, 2025, NGM TTM capital expenditures is $1.25 million, with the most recent change of -$253.00 thousand (-16.81%) on December 31, 2023.
- Over the past year, NGM TTM CAPEX has dropped by -$991.00 thousand (-44.18%).
Performance
NGM TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
NGM CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -32.6% | -71.9% | -44.2% |
3 y3 years | -33.4% | -31.4% | -33.4% |
5 y5 years | -78.6% | +75.7% | -64.1% |
NGM CAPEX Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -32.6% | at low | -77.1% | -44.7% | -44.2% | at low |
5 y | 5-year | -64.1% | at low | -84.3% | -44.7% | -64.1% | at low |
alltime | all time | -95.0% | at low | -95.3% | -44.7% | -81.0% | -17.5% |
NGM Biopharmaceuticals CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | $1.25 M(-32.6%) | $188.00 K(-35.2%) | $1.25 M(-16.8%) |
Sep 2023 | - | $290.00 K(+178.8%) | $1.50 M(-1.3%) |
Jun 2023 | - | $104.00 K(-84.5%) | $1.52 M(-32.0%) |
Mar 2023 | - | $670.00 K(+51.9%) | $2.24 M(+20.7%) |
Dec 2022 | $1.86 M(+10.3%) | $441.00 K(+42.3%) | $1.86 M(+19.9%) |
Sep 2022 | - | $310.00 K(-62.3%) | $1.55 M(+7.9%) |
Jun 2022 | - | $822.00 K(+188.4%) | $1.44 M(-20.6%) |
Mar 2022 | - | $285.00 K(+114.3%) | $1.81 M(+7.4%) |
Dec 2021 | $1.68 M(-10.4%) | $133.00 K(-32.1%) | $1.68 M(-7.7%) |
Sep 2021 | - | $196.00 K(-83.6%) | $1.82 M(+2.0%) |
Jun 2021 | - | $1.20 M(+646.9%) | $1.79 M(+21.4%) |
Mar 2021 | - | $160.00 K(-41.6%) | $1.47 M(-21.6%) |
Dec 2020 | $1.88 M | $274.00 K(+71.3%) | $1.88 M(-29.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2020 | - | $160.00 K(-81.8%) | $2.66 M(+0.2%) |
Jun 2020 | - | $880.00 K(+55.8%) | $2.66 M(+16.2%) |
Mar 2020 | - | $565.00 K(-46.6%) | $2.29 M(-34.4%) |
Dec 2019 | $3.49 M(-40.3%) | $1.06 M(+583.2%) | $3.49 M(+37.5%) |
Sep 2019 | - | $155.00 K(-69.5%) | $2.54 M(-17.0%) |
Jun 2019 | - | $509.00 K(-71.2%) | $3.06 M(-53.5%) |
Mar 2019 | - | $1.77 M(+1550.5%) | $6.58 M(+12.5%) |
Dec 2018 | $5.84 M(-9.0%) | $107.00 K(-84.1%) | $5.84 M(+1.9%) |
Sep 2018 | - | $674.00 K(-83.3%) | $5.74 M(+13.3%) |
Jun 2018 | - | $4.03 M(+290.1%) | $5.06 M(+390.1%) |
Mar 2018 | - | $1.03 M | $1.03 M |
Dec 2017 | $6.42 M(-74.1%) | - | - |
Dec 2016 | $24.80 M | - | - |
FAQ
- What is NGM Biopharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals annual CAPEX year-on-year change?
- What is NGM Biopharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals quarterly CAPEX year-on-year change?
- What is NGM Biopharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals TTM CAPEX year-on-year change?
What is NGM Biopharmaceuticals annual capital expenditures?
The current annual CAPEX of NGM is $1.25 M
What is the all time high annual CAPEX for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high annual capital expenditures is $24.80 M
What is NGM Biopharmaceuticals annual CAPEX year-on-year change?
Over the past year, NGM annual capital expenditures has changed by -$606.00 K (-32.62%)
What is NGM Biopharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of NGM is $188.00 K
What is the all time high quarterly CAPEX for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high quarterly capital expenditures is $4.03 M
What is NGM Biopharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, NGM quarterly capital expenditures has changed by -$482.00 K (-71.94%)
What is NGM Biopharmaceuticals TTM capital expenditures?
The current TTM CAPEX of NGM is $1.25 M
What is the all time high TTM CAPEX for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high TTM capital expenditures is $6.58 M
What is NGM Biopharmaceuticals TTM CAPEX year-on-year change?
Over the past year, NGM TTM capital expenditures has changed by -$991.00 K (-44.18%)